Tag: DrugSafety

What measures should be taken by Sponsors in case of missing investigation products during clinical trials in Turkiye

The loss of investigational products (IP) during a clinical trial severely influences the clinical trial’s integrity, participant safety, and regulatory compliance. When the absence of IPs is noticed during a clinical study, implementing the necessary measures by Sponsors in a timely manner is of great importance.